Previous Close | 8.08 |
Open | 8.09 |
Bid | 7.77 x 300 |
Ask | 7.83 x 700 |
Day's Range | 7.77 - 8.17 |
52 Week Range | 7.53 - 15.70 |
Volume | |
Avg. Volume | 4,574,927 |
Market Cap | 1.224B |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.
Ironwood Pharmaceuticals ( NASDAQ:IRWD ) Full Year 2023 Results Key Financial Results Revenue: US$442.7m (up 7.8% from...